Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Cardiovascular and Pulmonary Optimisation on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS

NCT04392089 is registered in ClinicalTrials.gov with Hvidovre University Hospital as lead sponsor.

NCT NCT04392089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04392089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Cardiovascular and Pulmonary Optimisation on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS
Lead sponsor
Hvidovre University Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2020
Completion date
May 1, 2021
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, respiratory failure